Isomorphic Labs raises $5 billion Series C to scale its AI drug design engine
Isomorphic Labs, the AI drug design company backed by Alphabet, has raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital, six months after a $2.1 billion Series B.
